查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
心臟定位市場規模、佔有率及成長分析（按類型、適應症、最終用戶和地區分類）－2026-2033年產業預測
市場調查報告書
商品編碼
1898039

心臟定位市場規模、佔有率及成長分析（按類型、適應症、最終用戶和地區分類）－2026-2033年產業預測

Cardiac Mapping Market Size, Share, and Growth Analysis, By Type (Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems), By Indication (Atrial Fibrillation, Atrial Flutter), By End User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球心臟定位市場規模預計在 2024 年達到 21.6 億美元，從 2025 年的 23.5 億美元成長到 2033 年的 46.4 億美元，在預測期（2026-2033 年）內複合年成長率為 8.9%。

市場調查顯示，美國約有1,400萬人患有心律不整，這推動了對心臟定位系統的需求，使其成為先進的非侵入性解決方案。這項先進技術採集胸部電脈衝，並將其與電腦斷層掃描數據結合，產生高品質的心臟標測圖。這些精確的標測圖對於專家分析心臟複雜的節律模式至關重要。心臟定位能夠幫助醫療專業人員更深入地了解心律不整，從而實現更精準的診斷和個人化的治療方案。這項創新不僅改善了患者照護，也使心臟定位成為心臟病學領域的重要工具，標誌著心臟健康管理領域的重要發展趨勢。

全球心臟定位市場促進因素

全球心臟定位市場的成長主要受兩大關鍵因素驅動：心血管疾病發生率的不斷上升以及心臟定位診斷技術的持續創新。心血管疾病是全球首要死因，每年奪走數百萬人的生命，其中相當一部分是心臟病發作和中風造成的。這一令人擔憂的趨勢凸顯了對先進診斷工具的迫切需求。隨著醫療機構致力於改善患者預後，對先進心臟定位系統的需求持續成長，從而推動了這一重要領域的進一步發展和投資。

限制全球心臟定位市場發展的因素

影響全球心臟定位市場的主要限制因素之一是心臟影像影像程序日益複雜。隨著心臟疾病診斷和治療方法的不斷完善，對先進技術和專業技能的需求也日益成長。這種複雜性可能會對醫療服務提供者造成障礙，尤其是在培訓和資源分配方面，從而減緩心臟定位技術的廣泛應用。此外，將這些先進程序整合到現有醫療系統中的複雜性可能導致成本增加，並可能對維持高效的工作流程構成挑戰，從而阻礙市場成長。

全球心臟定位市場趨勢

全球心臟定位市場正經歷顯著擴張，這主要得益於對先進心臟診斷技術日益成長的需求。醫療設備製造商的創新引領著這一趨勢，不斷提升心臟評估的準確性和效率。醫護人員和患者對心臟健康的意識提升以及對精準檢測技術的需求，進一步推動了這一發展趨勢。此外，將先進的影像技術和人工智慧應用於心臟定位，有助於改善患者預後並提高手術效率。隨著醫療系統將早期檢測和個人化治療置於優先地位，預計該市場在不久的將來將實現顯著成長。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數（2025）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 監管環境

全球心臟定位市場規模（按類型和複合年成長率分類）（2026-2033 年）

  • 接觸式心臟定位系統
  • 非接觸式心臟定位系統

全球心臟定位市場規模（按適應症和複合年成長率分類）（2026-2033 年）

  • 心房顫動
  • 心房撲動
  • 房室結折返性心搏過速（AVNRT）
  • 其他跡象

全球心臟定位市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

  • 醫院和診所
  • 診斷中心
  • 其他最終用戶

全球心臟定位市場規模及複合年成長率（2026-2033）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2025 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2025 年）
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Biosense Webster, Inc.（USA）
  • Abbott Laboratories（USA）
  • Boston Scientific Corporation（USA）
  • Medtronic plc（Ireland）
  • Acutus Medical, Inc.（USA）
  • AngioDynamics（USA）
  • Koninklijke Philips NV（Netherlands）
  • Biosig Technologies, Inc.（USA）
  • MicroPort Scientific Corporation（China）
  • Lepu Medical Technology（Beijing）Co., Ltd.（China）
  • Siemens Healthineers AG（Germany）
  • GE Healthcare（USA）
  • Johnson & Johnson（USA）
  • St. Jude Medical, Inc.（USA）
  • CardioInsight Technologies, Inc.（USA）
  • EP Solutions SA（Switzerland）
  • CathVision ApS（Denmark）
  • Acutus Medical, Inc.（USA）
  • MedLumics（Spain）

結論與建議

簡介目錄
Product Code: SQMIG35A2783

Global Cardiac Mapping Market size was valued at USD 2.16 Billion in 2024 and is poised to grow from USD 2.35 Billion in 2025 to USD 4.64 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

Market insights reveal that around 14 million people in the U.S. are affected by heart rhythm disorders, driving the growth of cardiac mapping systems as a sophisticated and non-invasive solution. This advanced technique collects electrical impulses from the chest, integrating them with data from computed tomography (CT) scans to produce high-quality cardiac maps. These intricate maps are essential for specialists as they analyze complex rhythm patterns of the heart. By utilizing cardiac mapping, healthcare professionals gain deeper insights into heart rhythm disorders, enabling more precise diagnoses and personalized treatment strategies. This innovation not only enhances patient care but also positions cardiac mapping as a critical tool in the realm of cardiology, signaling a significant trend in the management of heart health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Mapping Market Segments Analysis

Global Cardiac Mapping Market is segmented by Type, Indication, End User and region. Based on Type, the market is segmented into Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems. Based on Indication, the market is segmented into Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Mapping Market

The growth of the global cardiac mapping market is primarily driven by two significant factors: the increasing incidence of cardiovascular disorders and ongoing technological innovations in cardiac mapping diagnostics. Cardiovascular diseases are recognized as the primary cause of global mortality, leading to millions of deaths each year, with a considerable number of these fatalities resulting from heart attacks and strokes. This alarming trend highlights the urgent need for advanced diagnostic tools. As healthcare providers seek to improve patient outcomes, the demand for sophisticated cardiac mapping systems continues to rise, fostering further development and investment in this crucial sector.

Restraints in the Global Cardiac Mapping Market

One significant restraint influencing the Global Cardiac Mapping market is the growing complexity associated with cardiac imaging treatments. As the methodologies for diagnosing and managing cardiac conditions become more sophisticated, the need for advanced technologies and specialized skill sets intensifies. This complexity can create barriers for healthcare providers, particularly in terms of training and resource allocation, ultimately slowing down the widespread adoption of cardiac mapping techniques. Furthermore, the intricacies involved in integrating these advanced procedures into existing healthcare frameworks may lead to increased costs and potential challenges in maintaining streamlined workflows, thereby hindering market growth.

Market Trends of the Global Cardiac Mapping Market

The Global Cardiac Mapping market is experiencing notable expansion, fueled by the rising demand for advanced cardiac diagnostic technologies. Innovations from medical device companies are at the forefront, enhancing the precision and efficiency of cardiac assessments. This trend is further propelled by an increasing awareness of cardiac health and the need for accurate testing methods among healthcare providers and patients alike. Additionally, the integration of advanced imaging techniques and artificial intelligence in cardiac mapping is driving improvements in patient outcomes and procedural efficiencies. As healthcare systems prioritize early detection and personalized treatment, the market is poised for significant growth in the foreseeable future.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape

Global Cardiac Mapping Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Contact Cardiac Mapping Systems
  • Non-Contact Cardiac Mapping Systems

Global Cardiac Mapping Market Size by Indication & CAGR (2026-2033)

  • Market Overview
  • Atrial Fibrillation
  • Atrial Flutter
  • Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
  • Other Indications

Global Cardiac Mapping Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals and Clinics
  • Diagnostic Centers
  • Other End Users

Global Cardiac Mapping Market Size & CAGR (2026-2033)

  • North America (Type, Indication, End User)
    • US
    • Canada
  • Europe (Type, Indication, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Indication, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Indication, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Indication, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Biosense Webster, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acutus Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biosig Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology (Beijing) Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • St. Jude Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardioInsight Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EP Solutions SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CathVision ApS (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acutus Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedLumics (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations